Dr. Mattke is a Scientist at RAND and an expert in measuring performance and value in the healthcare system. He currently co-leads an MCAN-sponsored evidence review for gaps in asthma care, the impact and the cost and benefit of closing gaps as well as a related project to estimate the impact of insufficient pharmacological treatment for asthma on cost and utilization. He recently completed a review of the evidence for the impact of disease management on cost and quality of common chronic conditions and is conducting various projects related to disease management evaluation. Dr. Mattke was RAND’s Principal Investigator on the CMS Measures Manager development project, where he led the task of designing policies and procedures for measures maintenance and currently is RAND’s Principal Investigator on a CMS project to develop medication measures to ensure quality and efficiency under the Part D benefit. Prior to coming to RAND, Dr. Mattke was an administrator at the Health Policy Unit of the Organization for Economic Co-operation and Development (OECD), an intergovernmental research organization in Paris, where he directed the Health Care Quality Indicators Project. This project brings together 23 industrialized countries, international organizations, such the World Health Organization and the European Commission, research institutions, like the International Society for Quality in Healthcare and various academic experts in an attempt to develop a system for comparing quality of care internationally at the health systems level. The project recently released a first set of indicators and consensus statements on how to measure quality in five priority areas. Before that, he worked on quality of care research at Harvard University and Abt Associates, Inc.